Kevin Gorman

Founder at NEUROCRINE BIOSCIENCES, INC.

Net worth: 81 M $ as of 2026-05-30

68 year

Health Technology

Consumer Services

Profile

Founder of Neurocrine Biosciences, Inc., Kevin Charles Gorman presently is Chief Executive Officer & Director at this company. He is also on the board of Xencor, Inc. In his past career Dr. Gorman was Principal at Avalon Medical Partners LP. He received a doctorate and an MBA from the University of California, Los Angeles.

Known holdings in public companies

Company	Date	Number of shares	Valuation	Valuation date
NEUROCRINE BIOSCIENCES, INC. 0.51%	2026-05-26	511,293 ( 0.51% )	81 M $	2026-05-30
XENCOR, INC. 0.01%	2026-02-27	5,219 ( 0.01% )	62 002 $	2026-05-30

Kevin Gorman active positions

Companies	Position	Start
NEUROCRINE BIOSCIENCES, INC.	Founder	1991-12-31
XENCOR, INC.	Director/Board Member	2017-04-13

All active positions of Kevin Gorman

Former positions of Kevin Gorman

Companies	Position	End
Avalon Medical Partners LP	Corporate Officer/Principal	1992-12-31

See the detail of Kevin Gorman's experience

Training of Kevin Gorman

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Kevin Gorman's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	4
Neurocrine Biosciences, Inc. Neurocrine Biosciences, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes treatments for neurological, neuroendocrine and neuropsychiatric disorders	Health Technology
Xencor, Inc. Xencor, Inc. BiotechnologyHealth Technology Develops therapeutics to treat autoimmune and allergic diseases, cancer and other conditions	Health Technology
University of California, Los Angeles University of California, Los Angeles Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Avalon Medical Partners LP